Alyeska Investment Group
BLU

Alyeska Investment Group’s BELLUS Health Inc. BLU Stock Holding History

Alyeska Investment Group’s Portfolio BLU Stock Details BLU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-61,730
Closed -$425K – 690
2022
Q1 		$425K Sell
61,730
-13,270
-18% -$85.5K ﹤0.01% 554
2021
Q4 		$604K Buy
+75,000
New +$498K 0.01% 554
2020
Q1 		– Sell
-70,516
Closed -$536K – 507
2019
Q4 		$536K Buy
70,516
+268
+0.4% +$1.83K 0.01% 354
2019
Q3 		$449K Buy
+70,248
New +$496K 0.01% 365

Other funds holding BLU

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
PCOC
Power Corp of Canada Montreal, Quebec, Canada $745M AUM 22.7% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Alyeska Investment Group's BLU Position: Q2 2022 in Review

Alyeska Investment Group sold out of BELLUS Health Inc. (BLU) in Q2 2022, closing a stake of 61,730 shares — an estimated $425K sold.

Alyeska Investment Group first reported a position in BLU in Q3 2019 and held it in 4 quarters. The position peaked at $604K in Q4 2021. 94 funds tracked by Wall St. Rank hold BLU as of Q2 2022.

  • Alyeska Investment Group reported no remaining BELLUS Health Inc. position as of Q2 2022 after selling out during the quarter.
  • Alyeska Investment Group sold 61,730 BELLUS Health Inc. shares in Q2 2022, an estimated $425K.
  • Alyeska Investment Group first reported a position in BELLUS Health Inc. in Q3 2019 and held it in 4 quarters.
  • Alyeska Investment Group's BELLUS Health Inc. position peaked at $604K in Q4 2021.
  • 94 funds tracked by Wall St. Rank held BELLUS Health Inc. as of Q2 2022.

Based on Alyeska Investment Group's 13F filing for Q2 2022, filed 15 Aug 2022.